Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer

Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer have?

Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer has 222 citations in the OpenAlex counts ScholarIQ stores.

When was Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer published?

Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer has 2024 year in the ScholarIQ index.

What is the open-access status of Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer?

Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer has green oa status in the ScholarIQ index.

What is the DOI of Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer?

The DOI for Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer is on the source record.

What is the PMID of Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer?

The PMID for Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer is on the source record.

What is the OpenAlex record for Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer?

The OpenAlex for Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer is on the source record.